We serve Chemical Name:Endo-hexahydro-8-hydroxy-2.6- methano-2H-quinolizin-3(4H)-one CAS:115956-07-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Endo-hexahydro-8-hydroxy-2.6- methano-2H-quinolizin-3(4H)-one
CAS.NO:115956-07-5
Synonyms:Endo-hexahydro-8-hydroxy-2.6-methano-2H-quinolizin-3(4H)-one;endo-8-Hydroxyhexahydro-1H-2,6-methanoquinolizin-3(2H)-one;MFCD08460101;(2a,6a,8a,9ab)-Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one;AC-1648
Molecular Formula:C10H15NO2
Molecular Weight:181.23200
HS Code:2914400090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:356ºC
Density:1.28
Index of Refraction:1.589
PSA:40.54000
Exact Mass:181.11000
LogP:0.11090
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Endo-hexahydro-8-hydroxy-2.6-methano-2H-quinolizin-3(4H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,AC-1648 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,endo-8-Hydroxyhexahydro-1H-2,6-methanoquinolizin-3(2H)-one Use and application,MFCD08460101 technical grade,usp/ep/jp grade.
Related News: Walmsley’s background in consumer health—and lack of prior experience in pharma—has reportedly been targeted by Elliott in the investment firm’s secret push for a new boss at GSK. Bromo(2,5-dimethylphenyl)magnesium manufacturers The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said. 2-(N-Methyloleamido)acetic acid suppliers Walmsley’s background in consumer health—and lack of prior experience in pharma—has reportedly been targeted by Elliott in the investment firm’s secret push for a new boss at GSK. 1,2,3-trifluoro-5-methoxybenzene vendor & factory Only four out of the eight studies showed a reduction in ‘off’ time, and the effect did not increase with an increased dose of Nouryant.”,Walmsley’s background in consumer health—and lack of prior experience in pharma—has reportedly been targeted by Elliott in the investment firm’s secret push for a new boss at GSK.
